Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.33 |
| ▸ | MPL | P40238 | 1/20 | 0.33 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12172983 | 0.92 | FUT8 (0.35) | FUT8CYP1A2ALDH1A1MPLCTRC | |
| SCHEMBL12974316 | 0.91 | FUT8 (0.57) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL12646578 | 0.91 | FUT8 (0.57) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL19754269 | 0.90 | FUT8 (0.47) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL14022709 | 0.85 | FUT8 (0.58) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL12172963 | 0.85 | FUT8 (0.58) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL12173273 | 0.83 | FUT8 (0.45) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL12589961 | 0.83 | FUT8 (0.45) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL12589894 | 0.82 | FUT8 (0.45) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL13815202 | 0.82 | FUT8 (0.45) | FUT8CYP1A2CYP2C9MAPK1DNASE1L3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | FUT8 769/4885CYP1A2 4304/4885CYP2C9 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.